Board of Directors

Charles Morgan is a venture capitalist who has identified emerging sectors and acquired early stage and strategic positions in a wide range of ventures around the globe. He has a number of successful exits to his name, including the private acquisition of approximately 150,000 acres of oil and gas leases within the Marcellus Shale in North East Pennsylvania, USA. Having built this position in the early 2000s the acreage was farmed out, drilled and the working interests eventually sold to Chesapeake Energy, while retaining an ongoing royalty. He was also a founder of Clarity Pharmaceuticals Ltd, Australia’s largest pharma ASX IPO.

Charles started his career in futures and stock broking in London, Sydney, Melbourne and Perth prior to entering the oil and gas exploration business where he put together projects in the Philippines, Australia, West Africa, USA and Europe. During this time he also initiated a number of biotech projects. He was awarded an honorary PhD by Curtin University in Australia for his services to the commercialisation of technology.

Charles also serves on the Company’s Scientific Advisory Board.